SLNSW-Orteronel plus prednisone in patients with chemot...-TN_cdi_proquest_miscellaneous_1751215372

Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial

Full title: Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial

Author/creator: for the ELM-PC 4 investigators, ELM-PC 4 investigators, Saad, Fred, Dr Prof, Fizazi, Karim, Prof, Jinga, Viorel, Prof, Efstathiou, Eleni, MD, Fong, Peter C, MD, Hart, Lowell L, MD, Jones, Robert, MD, McDermott, Raymond, MD, Wirth, Manfred, Prof, Suzuki, Kazuhiro, Prof, MacLean, David B, MD, Wang, Ling, PhD, Akaza, Hideyuki, Prof, Nelson, Joel, Prof, Scher, Howard I, Prof, Dreicer, Robert, Prof, Webb, Iain J, MD, de Wit, Ronald, Prof.

Call Numbers:

Record Identifier: TN_cdi_proquest_miscellaneous_1751215372

Language: English

Formats: Articles

Publishers: England: Elsevier Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751215372

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial

    Record identifier

    TN_cdi_proquest_miscellaneous_1751215372

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751215372

    Share

    Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751215372

    Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial

    Full title

    Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial

    Author / Creator

    for the ELM-PC 4 investigators ; ELM-PC 4 investigators ; Saad, Fred, Dr Prof ; Fizazi, Karim, Prof ; Jinga, Viorel, Prof ; Efstathiou, Eleni, MD ; Fong, Peter C, MD ; Hart, Lowell L, MD ; Jones, Robert, MD ; McDermott, Raymond, MD ; Wirth, Manfred, Prof ; Suzuki, Kazuhiro, Prof ; MacLean, David B, MD ; Wang, Ling, PhD ; Akaza, Hideyuki, Prof ; Nelson, Joel, Prof ; Scher, Howard I, Prof ; Dreicer, Robert, Prof ; Webb, Iain J, MD ; de Wit, Ronald, Prof

    Publisher

    England: Elsevier Ltd

    Journal title

    The lancet oncology, 2015, Vol.16 (3), p.338-348

    Record Identifier

    TN_cdi_proquest_miscellaneous_1751215372

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Adenocarcinoma - drug therapy Adenocarcinoma - enzymology Adenocarcinoma - mortality Adenocarcinoma - secondary Aged Androgens Antigens Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Asia Australia Biosynthesis Cancer Cancer therapies Care and treatment Chemotherapy Clinical trials Corticosteroids Cytochrome P-450 Cytochrome P-450 Enzyme Inhibitors - administration & dosage Disease Progression Disease-Free Survival Double-Blind Method Drug dosages Europe Hematology, Oncology and Palliative Medicine HIV Hospitals Human immunodeficiency virus Humans Imidazoles - administration & dosage Intention to Treat Analysis Kaplan-Meier Estimate Male Medical colleges Medical treatment Metastasis Naphthalenes - administration & dosage New Zealand North America Pain Prednisone Prednisone - administration & dosage Proportional Hazards Models Prostate cancer Prostatic Neoplasms, Castration-Resistant - drug therapy Prostatic Neoplasms, Castration-Resistant - enzymology Prostatic Neoplasms, Castration-Resistant - mortality Prostatic Neoplasms, Castration-Resistant - pathology Risk Factors SDG 3 - Good Health and Well-being Steroid 17-alpha-Hydroxylase - antagonists & inhibitors Steroid 17-alpha-Hydroxylase - metabolism Steroids Time Factors Treatment Outcome

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_miscellaneous_1751215372

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751215372

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections